Clinical Trials in Nashville

Showing 5861-5880 of 15,379 trials

A Study to Evaluate Rucaparib in Combination With Other Anticancer Agents in Participants With a Solid Tumor (SEASTAR)

NCT03992131

This is an open label, Phase 1b/2 study with multiple treatment arms evaluating the safety, tolerability, pharmacokinetics (PK), and preliminary efficacy of rucaparib in combination with a second anticancer therapy in participants with an advanced/metastatic solid malignancy (Phase 1b), followed by evaluation of the combination in one or more specific participant populations in an expansion phase (Phase 2 cohorts).

Ovarian CancerTriple-negative Breast CancerUrothelial Carcinoma+1 more

pharmaand GmbH25 participantsStarted Jun 2019

Boston, Massachusetts, United States • Nashville, Tennessee, United States • Houston, Texas, United States

COMPLETEDNA< 1 mile

A Study to EXhibit Percutaneous Coronary Artery Dilatation With Non-Slip Element Balloon

NCT04985773

The objective of this study is to evaluate safety and effectiveness of the Lacrosse NSE ALPHA coronary dilatation catheter during PCI in subjects with stenotic coronary arteries.

Coronary StenosisCoronary Artery StenosisIn-stent Restenosis

Infraredx200 participantsStarted Dec 2021

Palo Alto, California, United States • Lexington, Kentucky, United States • Maplewood, Minnesota, United States +7 more locations

A Study to Evaluate Rucaparib in Combination With Other Anticancer Agents in Participants With a Solid Tumor (SEASTAR)

A Study to EXhibit Percutaneous Coronary Artery Dilatation With Non-Slip Element Balloon

Find Trials by Condition in Nashville

B0151005 Open-Label Extension Study

Non-Myeloablative Conditioning and Bone Marrow Transplantation

Clinical Research Study With Clazosentan to Evaluate Its Effects on Preventing Complications Due to the Narrowing of the Blood Vessels (Vasospasm) in the Brain, Caused by Bleeding Onto the Surface of the Brain

Clostridium Difficile Vaccine 2-Dose Versus 3-Dose Study

Comparison of Participants Who Received a CanGaroo® Envelope, TYRX™ Envelope, or no Envelope During CIED Implantation

A Study of LY3457263 Alone and in Combination With Dulaglutide (LY2189265) in Participants With Type 2 Diabetes

A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis

Diagnostic Performance of Small RNA Blood Test in Patients Undergoing Follow-up Imaging After Positive Low Dose CT Screening for Cancer of the Lung

Study Evaluating Betrixaban in Pediatric Participants

Congenital Heart Disease: Impact on Learning and Development in Down Syndrome (CHILD-DS)

A Study of PTC923 in Participants With Phenylketonuria

Antigen-specific T Cell Therapy for AML or MDS Patients With Relapsed Disease After Allo-HCT

A Phase I/II Study of MLN0128 in Metastatic Anaplastic Thyroid Cancer and Incurably Poorly Differentiated or Radioidodine Refractory Differentiated Thyroid Cancer

Study of Probable Benefit of the Neuro-Spinal Scaffold™ in Subjects With Complete Thoracic AIS A Spinal Cord Injury as Compared to Standard of Care

The Effect of In-utero Exposure to Metformin in 5-11 Year Old Offspring of Mothers in the MiTy Trial

A Study of CFI-400945 Fumarate in Patients With Advanced Cancer

A Study of Olaparib Prior to Surgery and Chemotherapy in Ovarian, Primary Peritoneal, and Fallopian Tube Cancer

Study of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological Malignancies